Clinical Trials Directory

Trials / Completed

CompletedNCT04901598

Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome

Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome: an Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate the physical activity level, aerobic capacity and dietary habits among a cohort of females with premenstrual syndrome

Detailed description

premenstrual syndrome can be defined as a recurrent disorder that occurs every month in the luteal phase of the menstrual cycle, and subside with the onset of menstruation. It is characterized by a complex set of symptoms, which include physical, psychological and behavioral changes with varying severity. This can interfere with the lives of females. Physical exercise improves PMS through rising endorphin levels, reducing adrenal cortisol symptoms, leading to lesser anxiety, depression and greater pain tolerance, as previous studies showed that it was effective in decreasing pain as well as mental and physical symptoms of PMS. Recently, lifestyle changes have gained more importance than pharmacotherapy. Lifestyle changes include many methods including diet regulation and exercise. 30 minutes of aerobic exercise is recommended for at least 3 days per week to contribute to the regulation of both body composition, mood and to improve physical symptoms. Evidence suggests that it can be helpful in reducing symptoms.

Conditions

Interventions

TypeNameDescription
OTHERRunning anaerobic sprint test and aerobic testsubjects walk a mile with maximum steps and their heart rate will not exceed 180 beats per minute during the test and the execution time will not be less than 9 minutes (RAST test)

Timeline

Start date
2021-10-20
Primary completion
2022-01-01
Completion
2022-03-25
First posted
2021-05-25
Last updated
2022-07-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04901598. Inclusion in this directory is not an endorsement.